SPTX reports positive topline data from Phase 1 driving trial
Seaport reported positive topline data from a Phase 1 driving simulation trial of GlyphAllo and dosed the first patient in a Phase 2a trial of GlyphAgo, with cash runway expected to fund operations into 2029.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed